• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » UPDATE: NeuWave Med raises $25m

UPDATE: NeuWave Med raises $25m

May 28, 2015 By Mark Hollmer

NeuWave Med raises $25m

UPDATED May 28, 2015, with details on investors, comment from management.

NeuWave Medical – developer of a microwave ablation tumor removal tool – pulled in more than $25.3 million in a Series C round led by Versant Ventures.

Madison, Wis.-based NeuWave said all of its existing backers also joined the over-subscribed round, including H.I.G. BioVentures, Venture Investors and others.

NeuWave calls its main product, the Certus 140, an "intelligent ablation system." It’s designed to deliver focused microwave ablation to destroy soft-tissue tumors in the lung, liver and kidney, the company said.

Proceeds from the Series C round are earmarked for expanding NeuWave’s commercial footprint and developing the next generation in its pipeline, according to a press release.

Versant managing director Kirk Nielsen joined NeuWave’s board as part of the round, the company said.

"The NeuWave intelligent ablation system has the potential to advance the treatment of multiple soft-tissue lesion types and improve the quality of life for millions of patients while reducing the cost of care," Nielsen said in prepared remarks. "We are excited about the potential of this platform technology and look forward to working with NeuWave’s experienced team to build a very successful company."

"NeuWave Medical’s Intelligent Ablation System is a proven technology for the ablation of soft-tissue lesions, including primary and metastatic lesions in the lung, liver and kidney which combined represent more than 11.6 million new patients each year," added president & CEO Dan Sullivan. "With this round of financing, we are well positioned to accelerate our commercial and R&D expansion plans to advance our mission of offering cost-effective and clinically efficacious alternatives for millions of patients worldwide."

Sullivan’s had a hand in several medtech startups, including Vascular Science, which was sold to St. Jude Medical (NYSE:STJ), and Atritech, which Boston Scientific (NYSE:BSX) subsequently snatched up in a $375 million deal.

Co-founder Fred Lee Jr. is a professor of radiology at University of Wisconsin-Madison.

Previous funding rounds for NeuWave including a $14 million Series B in 2012 and a planned $19 million equity funding in 2013.

Filed Under: Funding Roundup, News Well Tagged With: NeuWave Medical Inc.

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy